Alkem Laboratories Balance Sheet Health
Financial Health criteria checks 6/6
Alkem Laboratories has a total shareholder equity of ₹102.2B and total debt of ₹14.4B, which brings its debt-to-equity ratio to 14.1%. Its total assets and total liabilities are ₹149.3B and ₹47.0B respectively. Alkem Laboratories's EBIT is ₹19.2B making its interest coverage ratio -23.2. It has cash and short-term investments of ₹36.1B.
Key information
14.1%
Debt to equity ratio
₹14.43b
Debt
Interest coverage ratio | -23.2x |
Cash | ₹36.10b |
Equity | ₹102.25b |
Total liabilities | ₹47.01b |
Total assets | ₹149.26b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 539523's short term assets (₹96.6B) exceed its short term liabilities (₹39.1B).
Long Term Liabilities: 539523's short term assets (₹96.6B) exceed its long term liabilities (₹7.9B).
Debt to Equity History and Analysis
Debt Level: 539523 has more cash than its total debt.
Reducing Debt: 539523's debt to equity ratio has reduced from 18.9% to 14.1% over the past 5 years.
Debt Coverage: 539523's debt is well covered by operating cash flow (142.3%).
Interest Coverage: 539523 earns more interest than it pays, so coverage of interest payments is not a concern.